Cellosaurus InCELL Hunter U2OS BCL2L1-BAX Protein Binding (CVCL_KW13)
| Cell line name | InCELL Hunter U2OS BCL2L1-BAX Protein Binding |
|---|---|
| Synonyms | InCELL Hunter U2OS Bcl2L1-Bax |
| Accession | CVCL_KW13 |
| Resource Identification Initiative | To cite this cell line use: InCELL Hunter U2OS BCL2L1-BAX Protein Binding (RRID:CVCL_KW13) |
| Comments | Population: Caucasian. Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA). Genetic integration: Method=Transfection; Gene=HGNC; 992; BCL2L1. Genetic integration: Method=Transfection; Gene=HGNC; 959; BAX (Note=With del 1-51 and 73-192). Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. |
| Sequence variations |
|
| Disease | Osteosarcoma (NCIt: C9145) Osteosarcoma (ORDO: Orphanet_668) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0042 (U2OS) |
| Sex of cell | Female |
| Age at sampling | 15Y |
| Category | Cancer cell line |
| Cross-references | |
| Cell line collections (Providers) | DiscoverX; 96-0009C3 |
| Encyclopedic resources | Wikidata; Q54897728 |
| Entry history | |
| Entry creation | 22-Aug-2017 |
| Last entry update | 10-Sep-2024 |
| Version number | 9 |